title: Cytokine modulation of liver annexin 1 expression during experimental endotoxemia.
abstract: Annexin 1 (ANXA1) is a calcium-binding protein endowed with anti-inflammatory properties. Using an extra-hepatic system, we showed that interleukin (IL)-6 regulates ANXA1 expression at the transcriptional level. The purpose of this study was to determine whether ANXA1 synthesis was modulated by IL-6 during experimental inflammation. We have compared liver ANXA1 expression during systemic and localized inflammatory reaction, using lipopolysaccharide (LPS) and turpentine. LPS treatment strongly induced ANXA1 expression in the liver of wild-type (WT) animals (+600%) whereas a modest increase (+60%) was measured in IL-6 knockout (KO) animals. Turpentine treatment did not affect the expression of ANXA1 in either animal type. LPS enhanced serum corticosteroid levels equally in WT and IL-6 KO mice, whereas higher tumor necrosis factor (TNF)-alpha and IL-1beta levels were released in IL-6 KO animals. Injection of mouse recombinant IL-6 to IL-6 KO animals before LPS or TNF-alpha challenge, replenished ANXA1 liver synthesis to that of WT animals. Exogenous ANXA1 but not ANXA5, administered to IL-6 KO mice before LPS challenge inhibited TNF-alpha release. We propose that ANXA1 acts as a novel acute phase protein, which is controlled in the liver by TNF-alpha and IL-6, and which may contribute to the resolution of systemic endotoxemia through a negative feedback on TNF-alpha release.
authors.affiliation: Department of Cell Biology, Institut Cochin de Génétique Moléculaire, Paris, France.
authors.forename: C
authors.initials: C
authors.lastname: de Coupade
authors.forename: M N
authors.initials: MN
authors.lastname: Ajuebor
authors.forename: F
authors.initials: F
authors.lastname: Russo-Marie
authors.forename: M
authors.initials: M
authors.lastname: Perretti
authors.forename: E
authors.initials: E
authors.lastname: Solito
mesh_terms: D000818:Animals; D017302:Annexins / Q000378:metabolism*; D000906:Antibodies / Q000494:pharmacology; D003345:Corticosterone / Q000097:blood; D016207:Cytokines / Q000502:physiology*; D019446:Endotoxemia / Q000378:metabolism*; D022781:Hepatocytes / Q000378:metabolism; D007150:Immunohistochemistry; D007267:Injections; D007375:Interleukin-1 / Q000037:antagonists & inhibitors / Q000097:blood; D015850:Interleukin-6 / Q000235:genetics / Q000276:immunology / Q000494:pharmacology; D008070:Lipopolysaccharides / Q000494:pharmacology; D008099:Liver / Q000378:metabolism*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout / Q000235:genetics; D009994:Osmolar Concentration; D011994:Recombinant Proteins / Q000494:pharmacology; D012016:Reference Values; D014018:Tissue Distribution; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis / Q000037:antagonists & inhibitors / Q000276:immunology
chemical_list: D017302:Annexins; D000906:Antibodies; D016207:Cytokines; D007375:Interleukin-1; D015850:Interleukin-6; D008070:Lipopolysaccharides; D011994:Recombinant Proteins; D014409:Tumor Necrosis Factor-alpha; D003345:Corticosterone